10X Genomics Inc (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single-cell ATAC sequencer, and single-cell with barcode technology. The company offers single-cell gene expression, single-cell immune profiling, single-cell CNV, genome sequencing, exome sequencing, de novo assembly applications. 10X Genomics sells the products under the brand name Chromium. It offers services in the field of research, which includes cancer research, genetic health, agrigenomics, and population genetics. The company has operations in the US and the Netherlands. 10X Genomics is headquartered in Pleasanton, California, the US.
Headquarters
United States of America
Address
6230 Stoneridge Mall Road, Pleasanton, California, 94588
Website
www.10xgenomics.com
Telephone
1 925 4017300
No of Employees
1,239
Industry
Medical Equipment
Ticker Symbol & Exchange
TXG (NASD)
Revenue (2021)
$490.5M
64.1%
(2021 vs 2020)
EPS
XXX
Net Income (2021)
XXX
89.3%
(2021 vs 2020)
Market Cap*
$4.7B
Net Profit Margin (2021)
XXX
93.5%
(2021 vs 2020)
* As of and is in US$
Products and Services
| Products | Services |
|---|---|
| Products | Services |
| Chromium Controller | Single Cell Gene Expression |
| Single Cell ATAC Sequencer | Single Cell Immune Profiling |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | New Products/Services | In April, the company announced the commercial availability of two new products, Fixed RNA Profiling and Nuclei Isolation Kits. |
| 2022 | Others | In February, the company unveiled new details about upcoming products and capabilities across its single cell, spatial, and in situ platforms at its second annual Xperience 2022 virtual event. |
| 2022 | Contracts/Agreements | In January, the company and Olink Proteomics entered into a partnership with Psomagen, Inc to accelerate the impact of Multiomics on human health. |
Competitor Comparison
| Key Parameters | 10X Genomics Inc | Spero Therapeutics Inc | Abiant Inc | Amgen | Murrieta Genomics LLC |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Pleasanton | Cambridge | Grayslake | - | Murrieta |
| State/Province | California | Massachusetts | Illinois | California | California |
| No. of Employees | 1,239 | 146 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Stuelpnagel | Chairman | Executive Board | 2013 | 63 |
| Serge Saxonov | Director; Chief Executive Officer | Executive Board | 2012 | 44 |
| Benjamin J. Hindson | President; Chief Scientific Officer; Director | Executive Board | 2012 | 46 |
| Justin McAnear | Chief Financial Officer | Senior Management | 2018 | 45 |
| Jean M. Philibert | Chief People Officer | Senior Management | 2018 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer